APA
Kang K., Chuai J., Xie B., Li J., Qu H., Wu H., Fang S., Cui J., Xiu L., Han J., Cao T., Leng X., Tian H., Li R. & Jiang S. (20210430). Mesenchymal Stromal Cells from Patients with Cyanotic Congenital Heart Disease are Optimal Candidate for Cardiac Tissue Engineering. : Biomaterials.
Chicago
Kang Kai, Chuai Jun-Bo, Xie Bao-Dong, Li Jian-Zhong, Qu Hui, Wu Hua, Fang Shao-Hong, Cui Jin-Jin, Xiu Li-Li, Han Jin-Cheng, Cao Tian-Hui, Leng Xiao-Ping, Tian Hai, Li Ren-Ke and Jiang Shu-Lin. 20210430. Mesenchymal Stromal Cells from Patients with Cyanotic Congenital Heart Disease are Optimal Candidate for Cardiac Tissue Engineering. : Biomaterials.
Harvard
Kang K., Chuai J., Xie B., Li J., Qu H., Wu H., Fang S., Cui J., Xiu L., Han J., Cao T., Leng X., Tian H., Li R. and Jiang S. (20210430). Mesenchymal Stromal Cells from Patients with Cyanotic Congenital Heart Disease are Optimal Candidate for Cardiac Tissue Engineering. : Biomaterials.
MLA
Kang Kai, Chuai Jun-Bo, Xie Bao-Dong, Li Jian-Zhong, Qu Hui, Wu Hua, Fang Shao-Hong, Cui Jin-Jin, Xiu Li-Li, Han Jin-Cheng, Cao Tian-Hui, Leng Xiao-Ping, Tian Hai, Li Ren-Ke and Jiang Shu-Lin. Mesenchymal Stromal Cells from Patients with Cyanotic Congenital Heart Disease are Optimal Candidate for Cardiac Tissue Engineering. : Biomaterials. 20210430.